Is the ``$1000 Genome'' really $1000? Understanding the full benefits and costs of genomic sequencing

Technol Health Care. 2015;23(3):373-9. doi: 10.3233/THC-150900.

Authors

Kathryn A Phillips¹, Mark J Pletcher², Uri Ladabaum³

Affiliations

¹ Center for Translational and Policy Research on Personalized Medicine, Department of Clinical Pharmacy, University of California at San Francisco, UCSF, San Francisco, CA, USA.
² Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA.
³ Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.

No abstract available

Keywords: Sequencing; cost-effectiveness; economics; price.

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Computer Simulation*
Cost-Benefit Analysis
Genetic Predisposition to Disease / genetics
Genetic Testing / economics*
Genomics / economics*
Humans
Mass Screening / economics
Models, Econometric*
Neoplasms / genetics

Grants and funding